Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis

Recent studies have shown that mieroRNA-21 (miR-21) con- tributes to tumor resistance to chemotherapy. Interestingly, we have found that berberine could inhibit miR-21 expres- sion in several cancer cell lines. In this study, we investigated whether berberine could modulate the sensitivity of ovaria...

Full description

Saved in:
Bibliographic Details
Published inActa biochimica et biophysica Sinica Vol. 45; no. 9; pp. 756 - 762
Main Authors Liu, Shiguo, Fang, Yue, Shen, Huiling, Xu, Wenlin, Li, Hao
Format Journal Article
LanguageEnglish
Published China 01.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent studies have shown that mieroRNA-21 (miR-21) con- tributes to tumor resistance to chemotherapy. Interestingly, we have found that berberine could inhibit miR-21 expres- sion in several cancer cell lines. In this study, we investigated whether berberine could modulate the sensitivity of ovarian cancer cells to cisplatin and explored the mechanism. The cisplatin-resistant SKOV3 cells that were incubated with berberine combined with cisplatin had a significantly lower survival than the cisplatin alone group and enhanced cis- platin-induced apoptosis. Berberine could inhibit miR-21 expression and function in ovarian cancer, as shown by an enhancement of its target PDCD4, an important tumor sup- pressor in ovarian cancer. The results suggested that berber- ine could modulate the sensitivity of cisplatin via regulating miR-21/PDCD4 axis in the ovarian cancer cells.
Bibliography:31-1940/Q
Recent studies have shown that mieroRNA-21 (miR-21) con- tributes to tumor resistance to chemotherapy. Interestingly, we have found that berberine could inhibit miR-21 expres- sion in several cancer cell lines. In this study, we investigated whether berberine could modulate the sensitivity of ovarian cancer cells to cisplatin and explored the mechanism. The cisplatin-resistant SKOV3 cells that were incubated with berberine combined with cisplatin had a significantly lower survival than the cisplatin alone group and enhanced cis- platin-induced apoptosis. Berberine could inhibit miR-21 expression and function in ovarian cancer, as shown by an enhancement of its target PDCD4, an important tumor sup- pressor in ovarian cancer. The results suggested that berber- ine could modulate the sensitivity of cisplatin via regulating miR-21/PDCD4 axis in the ovarian cancer cells.
ovarian cancer; berberine; miR-21
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-9145
1745-7270
DOI:10.1093/abbs/gmt075